Evidence map›Paper›PMID 25512410›Full record

ArticleAntimicrobial agents and chemotherapy2015

Do formulation differences between the reference listed drug and generic piperacillin-tazobactam impact reconstitution?

HaiAn Zheng, James Truong, Fred Carroll, Manjunath P Pai

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

HaiAn ZhengAlbany College of Pharmacy and Health Sciences, Albany, New York, USA haian.zheng@acphs.edu amit.pai@acphs.edu.
James TruongAlbany College of Pharmacy and Health Sciences, Albany, New York, USA.
Fred CarrollPfred Pharma Consulting, LLC, East Lyme, Connecticut, USA.
Manjunath P PaiAlbany College of Pharmacy and Health Sciences, Albany, New York, USA haian.zheng@acphs.edu amit.pai@acphs.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmaceutical differences between the reference listed drug (RLD) and generic formulations of piperacillin-tazobactam may impact the reconstitution process for intravenous administration. This study evaluated the RLD against three generic formulations and measured their reconstitution times using a standardized process. The mean (standard deviation [SD]) reconstitution time for one generic formulation was 5.57 (1.49) min, which was 35% to 42% longer (P < 0.002) than that for the RLD and two other formulations. Observable microscopic differences in powder particle morphology may explain these findings.

Indexed as

Administration, IntravenousAnti-Bacterial AgentsChemistry, PharmaceuticalDrugs, GenericPenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug CombinationTazobactamAnti-Bacterial AgentsDrugs, GenericPenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug CombinationTazobactam

Identifiers

PMID25512410
PMCPMC4325799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.